MREO - Mereo BioPharma Group plc

QQQ $ 602.61 $ 4.22 (0.71 %)

DIA $ 463.04 $ 0.00 (0 %)

SPY $ 665.11 $ 2.94 (0.44 %)

TLT $ 90.76 $ -0.20 (-0.22 %)

GLD $ 387.41 $ 6.60 (1.73 %)

Previous Close

$ 2.02

Open

$ 1.98

Bid

$ 1.95 x 126

Ask

$ 2.06 x 100

Day's Range

$ 1.96 - $ 2.04

52 Week Range

$ 1.47 - $ 4.72

Volume

1,275,499

Average Volume

Market Cap

321.38M

Beta (5Y Monthly)

$ 0.44

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2025	06-30-2025	10-Q
2	05-13-2025	03-31-2025	10-Q
3	03-26-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-13-2024	06-30-2024	10-Q
6	05-15-2024	03-31-2024	10-Q
7	03-27-2024	12-31-2023	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

JP Morgan Maintains Overweight on Mereo Bi...
08/25/2025 14:14:55

JP Morgan analyst Priyanka Grover maintains Mereo BioPharma Group (NASDAQ:MREO) with a Overweight and raises the price targe...

Mereo BioPharma And āshibio Announce Exclu...
08/19/2025 12:36:30

Mereo BioPharma Group Q2 EPS $(0.02) Misse...
08/12/2025 11:38:36

Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate ...

ultragenyx-represents-intriguing-buying-opportunity-despite-recent-setbacks

Ultragenyx Represents 'Intriguing Buying O...
07/28/2025 17:16:04

HC Wainwright initiates Ultragenyx at Buy with $80 target, citing strong rare disease pipeline and late-stage data expected by ...

12 Health Care Stocks Moving In Thursday's...
07/10/2025 17:05:47

crude-oil-down-over-2-delta-air-lines-posts-upbeat-earnings

Crude Oil Down Over 2%; Delta Air Lines Po...
07/10/2025 17:04:43

US Stocks Mixed; Initial Jobless Claims Fall
07/10/2025 14:46:41

ultragenyx-mereo-shares-dive-as-brittle-bone-disease-drug-misses-early-win

Ultragenyx, Mereo Shares Dive As Brittle B...
07/10/2025 14:06:42

Ultragenyx shares fall after Phase 3 study misses interim target, but analysts remain positive ahead of final OI data expected ...

12 Health Care Stocks Moving In Thursday's...
07/10/2025 12:09:22

methode-electronics-ultragenyx-pharmaceutical-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session

Methode Electronics, Ultragenyx Pharmaceut...
07/10/2025 12:00:22

Needham Maintains Buy on Mereo BioPharma G...
07/10/2025 10:19:13

Needham analyst Gil Blum maintains Mereo BioPharma Group (NASDAQ:MREO) with a Buy and lowers the price target from $7 to $5.

why-wk-kellogg-shares-are-trading-higher-by-over-50-here-are-20-stocks-moving-premarket

Why WK Kellogg Shares Are Trading Higher B...
07/10/2025 09:47:28

12 Health Care Stocks Moving In Wednesday'...
07/09/2025 21:06:40

Ultragenyx And Mereo BioPharma To Complete...
07/09/2025 20:08:08

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) and Mereo BioPharma Group plc (NASDAQ:MREO), today announced that the randomized, ...

rio-tinto-bumble-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

Rio Tinto, Bumble And Other Big Stocks Mov...
06/03/2025 12:31:22

why-credo-technology-group-shares-are-trading-higher-by-over-14-here-are-20-stocks-moving-premarket

Why Credo Technology Group Shares Are Trad...
06/03/2025 10:30:29

Needham Reiterates Buy on Mereo BioPharma ...
05/13/2025 14:01:01

Needham analyst Gil Blum reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Buy and maintains $7 price target.

CORRECTION: Mereo BioPharma Q1 GAAP EPS $(...
05/13/2025 12:41:32

Needham Reiterates Buy on Mereo BioPharma ...
04/09/2025 12:14:56

Needham analyst Gil Blum reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Buy and maintains $7 price target.

JP Morgan Initiates Coverage On Mereo BioP...
03/27/2025 12:15:08

JP Morgan analyst Priyanka Grover initiates coverage on Mereo BioPharma Group (NASDAQ:MREO) with a Overweight rating and ann...